Chemosensitive effects of Astragaloside IV in osteosarcoma cells via induction of apoptosis and regulation of caspase-dependent Fas/FasL signaling

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017;67(1):7–30. Wang X, Zheng H, Shou T, Tang C, Miao K, Wang P. Effectiveness of multi-drug regimen chemotherapy treatment in osteosarcoma patients: a network meta-analysis of randomized controlled trials. J Orthop Surg Res 2017;12(1):52. Liao Z, Nan G, Yan Z, Zeng L, Deng Y, Ye J, et al. The anthelmintic drug niclosamide inhibits the proliferative activity of human osteosarcoma cells by targeting multiple signal pathways. Curr Cancer Drug Targets 2015;15(8):726–38. Wang X, He H, Zhang K, Peng W. The expression of TSSC3 and its prognostic value in patients with osteosarcoma. Biomed Pharmacother 2016;79:23–6. Yang Z, Zhang Y, Zhang X, Zhang M, Liu H, Zhang S, et al. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma. Biomed Pharmacother 2015;75:153–8. Fanelli M, Hattinger CM, Vella S, Tavanti E, Michelacci F, Gudeman B, et al. Targeting ABCB1 and ABCC1 with their specific inhibitor CBT-1® can overcome drug resistance in osteosarcoma. Curr Cancer Drug Targets 2016;16(3):261–74. Yuan Z, Jiang H, Zhu X, Liu X, Li J. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-kB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer. Biomed Pharmacother 2017;89:227–32. Song S, Du L, Jiang H, Zhu X, Li J, Xu J. Paris saponin I sensitizes gastric cancer cell lines to cisplatin via cell cycle arrest and apoptosis. Med Sci Monit 2016;22:3798–803. Zhu X, Jiang H, Li J, Xu J, Fei Z. Anticancer effects of Paris saponins by apoptosis and Pi3K/AKT pathway in gefitinib-resistant non-small cell lung cancer. Med Sci Monit 2016;22:1435–41. Zheng R, Rao Y, Jiang H, Liu X, Zhu X, Li J, et al. Therapeutic potential of Ginsenoside Rg3 via inhibiting Notch/HES1 pathway in lung cancer cells. Transl Cancer Res 2016;5(4):464–9. Zhao PJ, Song SC, Du LW, Zhou GH, Ma SL, Li JH, et al. Paris Saponins enhance radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line by inducing apoptosis and G2/M cell cycle phase arrest. Mol Med Rep 2016;13(3):2878–84. Zhao P, Jiang H, Su D, Feng J, Ma S, Zhu X. Inhibition of cell proliferation by mild hyperthermia at 43 C with Paris Saponin I in the lung adenocarcinoma cell line PC-9. Mol Med Rep 2015;11(1):327–32. Jiang H, Zhao P, Feng J, Su D, Ma S. Effect of Paris saponin I on radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line. Oncol Lett 2014;7(6):2059–64. Jiang H, Zhao PJ, Su D, Feng J, Ma SL. Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo. Mol Med Rep 2014;9(6):2265–72. Zheng R, Jiang H, Li J, Liu X, Xu H. Polyphyllin II restores sensitization of the resistance of PC-9/zD cells to gefitinib by a negative regulation of the PI3K/Akt/mTOR signaling pathway. Curr Cancer Drug Targets 2017;17(4):376–85. Li L, Hou X, Xu R, Liu C, Tu M. Research review on the pharmacological effects of astragaloside IV. Fundam Clin Pharmacol 2017;31(1):17–36. Zhang S, Tang D, Zang W, Yin G, Dai J, Sun YU, et al. Synergistic inhibitory effect of traditional chinese medicine astragaloside IV and curcumin on tumor growth and angiogenesis in an orthotopic nude-mouse model of human hepatocellular carcinoma. Anticancer Res 2017;37(2):465–73. Qin CD, Ma DN, Ren ZG, Zhu XD, Wang CH, Wang YC, et al. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway. Oncol Rep 2017;37(3):1725–35. Jiang K, Lu Q, Li Q, Ji Y, Chen W, Xue X. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling. Int Immunopharmacol 2017;42:195–202. Cheng X, Gu J, Zhang M, Yuan J, Zhao B, Jiang J, et al. Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway. Int Immunopharmacol 2014;23(1):304–13. Zhang A, Zheng Y, Que Z, Zhang L, Lin S, Le V, et al. Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO. J Cancer Res Clin Oncol 2014;140(11):1883–90. OuYang Y, Huang J, OuYang Z, Kang J. Enrichment and purification process of astragalosides and their anti-human gastric cancer MKN-74 cell proliferation effect. Afr Health Sci 2014;14(1):22–7. Xie T, Li Y, Li SL, Luo HF. Astragaloside IV enhances cisplatin chemosensitivity in human colorectal cancer via regulating NOTCH3. Oncol Res 2016;24(6):447–53. He CS, Liu YC, Xu ZP, Dai PC, Chen XW, Jin DH. Astragaloside IV enhances cisplatin chemosensitivity in non-small cell lung cancer cells through inhibition of B7-H3. Cell Physiol Biochem 2016;40(5):1221–9. Wang PP, Xu DJ, Huang C, Wang WP, Xu WK. Astragaloside IV reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines. Mol Med Rep 2014;9(6):2131–7. Hattinger CM, Vella S, Tavanti E, Fanelli M, Picci P, Serra M. Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients. Pharmacogenomics 2016;17(18):2097–114. Yang JZ, Ma SR, Rong XL, Zhu MJ, Ji QY, Meng LJ, et al. Characterization of multidrug-resistant osteosarcoma sublines and the molecular mechanisms of resistance. Mol Med Rep 2016;14(4):3269–76. Li M, Jiang XG, Gu ZL, Zhang ZB. Glaucocalyxin A activates FasL and induces apoptosis through activation of the JNK pathway in human breast cancer cells. Asian Pac J Cancer Prev 2013;14(10):5805–10. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281(5381):1305–8. Thorburn A. Death receptor-induced cell killing. Cell Signal 2004;16(2):139–44. Wang H, Zhang X, Sun W, Hu X, Li X, Fu S, et al. Activation of TIM1 induces colon cancer cell apoptosis via modulating Fas ligand expression. Biochem Biophys Res Commun 2016;473(2):377–81. Zhang Y, Li D, Zhao X, Song S, Zhang L, Zhu D, et al. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells. Biochem Biophys Res Commun 2015;463(4):1144–51. Wu HY, Lin TK, Kuo HM, Huang YL, Liou CW, Wang PW, et al. Phyllanthus urinaria induces apoptosis in human osteosarcoma 143B cells via activation of fas/FasL- and mitochondria-mediated pathways. Evid Based Complement Altern Med 2012;2012:925824.